Skip to main content

Geriatric Pharmacotherapy: Optimisation Through Integrated Approach in the Hospital Setting

  • Chapter
  • First Online:
Developing Drug Products in an Aging Society

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 26))

Abstract

Since older patients are more vulnerable to adverse drug-related events, there is a need to ensure appropriate prescribing in these patients in order to prevent misuse, overuse and underuse of drugs. Different tools and strategies have been developed to reduce inappropriate prescribing; the available measures can be divided into medication assessment tools, and specific interventions to reduce inappropriate prescribing. Implicit criteria of inappropriate prescribing focus on appropriate dosing, search for drug-drug interactions, and increase adherence. Explicit criteria are consensus-based standards focusing on drugs and diseases and include lists of drugs to avoid in general or lists combining drugs with clinical data. These criteria take into consideration differences between patients, and stand for a medication review, by using a systematic approach. Different types of interventions exist in order to reduce inappropriate prescribing in older patients, such as: educational interventions, computerized decision support systems, pharmacist-based interventions, and geriatric assessment. The effects of these interventions have been studied, sometimes in a multifaceted approach combining different techniques, and all types seem to have positive effects on appropriateness of prescribing. Interdisciplinary teamwork within the integrative pharmaceutical care is important for improving of outcomes and safety of drug therapy. The pharmaceutical care process consists of four steps, which are cyclic for an individual patient. These steps are pharmaceutical anamnesis, medication review, design and follow-up of a pharmaceutical care plan. A standardized approach is necessary for the adequate detection and evaluation of drug-related problems. Furthermore, it is clear that drug therapy should be reviewed in-depth, by having full access to medical records, laboratory values and nursing notes. Although clinical pharmacists perform the pharmaceutical care process to manage the patient’s drug therapy in every day clinical practice, the physician takes the ultimate responsibility for the care of the patient in close collaboration with nurses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Somers A, Petrovic M, Robays H, Bogaert M. Reporting adverse drug reactions in a university hospital: a pilot project on a geriatric ward. Eur J Clin Pharmacol. 2003;58:707–14.

    Article  PubMed  Google Scholar 

  2. Somers A, Robays H, Vander Stichele R, Van Maele G, Bogaert M, Petrovic M. Contribution of drug related problems to hospital admission in the elderly. J Nutr Health Aging. 2010;14:477–82.

    Article  CAS  PubMed  Google Scholar 

  3. Classen D, Pestotnik S, Evans R, Lloyd J, Burke J. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–6.

    Article  CAS  PubMed  Google Scholar 

  4. Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.

    Article  CAS  PubMed  Google Scholar 

  5. Jha A, Kuperman G, Teich J, Leape L, Shea B, Rittenberg E, Burdick E, Seger D, Vander Vliet M, Bates D. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998;5:305–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Eland I, Belton K, van Grootheest A, Meiners A, Rawlins M, Stricker B. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48:623–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Beijer H, de Blaey C. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54.

    Article  CAS  PubMed  Google Scholar 

  8. Pirmohamed M, James S, Meakin S, Green C, Scott A, Walley T, Farrar K, Park B, Breckenridge A. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lindley C, Tully M, Paramsothy V, Tallis R. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing. 1992;21:294–300.

    Article  CAS  PubMed  Google Scholar 

  10. Leendertse A, Egberts A, Stoker L, van den Bemt P, HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;68:1890–6.

    Google Scholar 

  11. van den Bemt P, Egberts A, Lenderink A, Verzijl J, Simons K, van der Pol W, Leufkens H. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci. 2000;22:62–6.

    Article  PubMed  Google Scholar 

  12. Hajjar E, Hanlon J, Artz M, Lindblad C, Pieper C, Sloane R, Ruby C, Schmader K. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. 2003;1:82–9.

    Article  PubMed  Google Scholar 

  13. Field T, Gurwitz J, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates D. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;161:1629–34.

    Article  CAS  PubMed  Google Scholar 

  14. Field T, Gurwitz J, Harrold L, Rothschild J, Debellis K, Seger A, Fish L, Garber L, Kelleher M, Bates D. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52:1349–54.

    Article  PubMed  Google Scholar 

  15. Lund B, Carnahan R, Egge J, Chrischilles E, Kaboli P. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44:957–63.

    Article  PubMed  Google Scholar 

  16. Steinman M, Landefeld C, Rosenthal G, Berthenthal D, Sen S, Kaboli P. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516–23.

    Article  PubMed  Google Scholar 

  17. Page R, Linnebur S, Bryant L, Ruscin J. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Passarelli M, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22:767–77.

    Article  PubMed  Google Scholar 

  19. Batty G, Grant R, Aggarwal R, Lowe D, Potter J, Pearson M, Jackson S. Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients. Age Ageing. 2003;32:292–8.

    Article  PubMed  Google Scholar 

  20. Hanlon J, Artz M, Pieper C, Lindblad C, Sloane R, Ruby C, Schmader K. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38:9–14.

    Article  PubMed  Google Scholar 

  21. Perehudoff K, Azermai M, Somers A, Vander Stichele R, Petrovic M. Medication discrepancies in older patients admitted to non-geriatric wards: an exploratory study. Eur Geriatr Med. 2015;6:41–5.

    Article  Google Scholar 

  22. Petrovic M, Somers A, Onder G. Optimization of geriatric pharmacotherapy: role of multifaceted cooperation in the hospital setting. Drugs Aging. 2016;33(3):179–88.

    Article  CAS  PubMed  Google Scholar 

  23. Rochon P, Gurwitz J. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315:1096–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Onder G, Petrovic M, Tangiisuran B, Meinardi M, Markito-Notenboom W, Somers A, Rajkumar C, Bernabei R, van der Cammen T. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170:1142–8.

    Article  PubMed  Google Scholar 

  25. Tangiisuran B, Scutt G, Stevenson J, Wright J, Onder G, Petrovic M, van der Cammen T, Rajkumar C, Davies G. Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton Adverse Drug Reactions Risk (BADRI) model. PLoS ONE. 2014;9:e111254.

    Article  PubMed  PubMed Central  Google Scholar 

  26. O’Connor M, Gallagher P, Byrne S, O’Mahony D. Adverse drug reactions in older patients during hospitalisation: are they predictable? Age Ageing. 2012;41:771–6.

    Article  PubMed  Google Scholar 

  27. Berenguer B, La Casa C, de la Matta M, Martín-Calero M. Pharmaceutical care: past, present and future. Curr Pharm Des. 2004;10:3931–46.

    Article  CAS  PubMed  Google Scholar 

  28. Cipolle R, Strand L, Morley P. Pharmaceutical care practice. New York: Mc Graw Hill; 1998.

    Google Scholar 

  29. Somers A. Detection and prevention of drug related problems in older hospitalized patients—the challenge for the clinical pharmacist. PhD thesis, Ghent University. Ghent; 2012.

    Google Scholar 

  30. Spinewine A, Fialová D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29:495–510.

    Article  PubMed  Google Scholar 

  31. Kripalani S, Roumie C, Dalal A, Cawthon C, Businger A, Eden S, Shintani A, Sponsler K, Harris L, Theobald C, Huang R, Scheurer D, Hunt S, Jacobson T, Rask K, Vaccarino V, Gandhi T, Bates D, Williams M, Schnipper J; for the PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157:1–10.

    Google Scholar 

  32. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega J, Wilmotte L, Tulkens P. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55:658–65.

    Article  PubMed  Google Scholar 

  33. Chisholm-Burns M, Kim Lee J, Spivey C, Slack M, Herrier R, Hall-Lipsy E, Graff Zivin J, Abraham I, Palmer J, Martin J, Kramer S, Wunz T. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–33.

    Google Scholar 

  34. Klopotowska J, Kuiper R, van Kan H, de Pont A, Dijkgraaf M, Lie-A-Huen L, Vroom M, Smorenburg S. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14:R174.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Schnipper J, Hamann C, Ndumele C, Liang C, Carty M, Karson A, Bhan I, Coley C, Poon E, Turchin A, Labonville S, Diedrichsen E, Lipsitz S, Broverman C, McCarthy P, Gandhi T. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med. 2009;169:771–80.

    Article  PubMed  Google Scholar 

  36. Kucukarslan S, Peters M, Mlynarek M, Nafziger D. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.

    Article  PubMed  Google Scholar 

  37. Leape L, Cullen D, Clapp M, Burdick E, Demonaco H, Erickson J, Bates D. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.

    Article  CAS  PubMed  Google Scholar 

  38. Kaur S, Mitchell G, Vitetta L, Roberts M. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26:1013–28.

    Article  PubMed  Google Scholar 

  39. Spinewine A, Schmader K, Barber N, Hughes C, Lapane K, Swine C, Hanlon J. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84.

    Article  PubMed  Google Scholar 

  40. Hanlon J, Schmader K, Samsa G, Weinberger M, Uttech K, Lewis I, Cohen H, Feussner J. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.

    Article  CAS  PubMed  Google Scholar 

  41. Somers A, Mallet L, van der Cammen T, Robays H, Petrovic M. Applicability of an adapted Medication Appropriateness Index (MAI) for detection of drug related problems in geriatric inpatients. Am J Geriatr Pharmacother. 2012;10:101–9.

    Article  PubMed  Google Scholar 

  42. McLeod P, Huang A, Tamblyn R, Gayton D. Defining inappropriate practices in, prescribing for elderly people: a national consensus panel. Can Med Assoc J. 1997;456:385–91.

    Google Scholar 

  43. Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med. 2001;135:642–6.

    Article  CAS  PubMed  Google Scholar 

  44. Naugler C, Brymer C, Stolee P, Arcese Z. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7:103–7.

    CAS  PubMed  Google Scholar 

  45. Zhan C, Sangl J, Bierman A, Miller M, Friedman B, Wickizer S, Meyer G. Potentially inappropriate medication use in the community-dwelling elderly: findings from the1996 Medical Expenditure Panel Survey. JAMA. 2001;286:2823–9.

    Article  CAS  PubMed  Google Scholar 

  46. Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Grégoire J. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004;4:9.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Laroche M, Charmes J, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63:725–31.

    Article  PubMed  Google Scholar 

  48. Basger B, Chen T, Moles R. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging. 2008;25:777–93.

    Article  PubMed  Google Scholar 

  49. Basger B, Chen T, Moles R. Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open. 2012; 2(5).

    Google Scholar 

  50. Winit-Watjana W, Sakulrat P, Kespichayawattana J. Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr. 2008;47:35–51.

    Article  PubMed  Google Scholar 

  51. Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller T, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27:153–9.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Holt S, Schmiedl S, Thurmann P. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.

    PubMed  PubMed Central  Google Scholar 

  53. Beers M, Ouslander J, Rollingher I, Reuben D, Brooks J, Beck J. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825–32.

    Article  CAS  PubMed  Google Scholar 

  54. American Geriatrics Society. Beers Criteria update expert panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;2012(60):616–31.

    Google Scholar 

  55. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.

    Article  CAS  PubMed  Google Scholar 

  56. O’Mahony, O’Sullivan D, Byrne S, O’Connor M, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015; 44:213–8.

    Google Scholar 

  57. Davidoff AJ, Miller GE, Sarpong EM, Yang E, Brandt N, Fick DM. Prevalence of potentially inappropriate medication use in older adults using the 2012 Beers Criteria. J Am Geriatr Soc. 2015. [Epub ahead of print].

    Google Scholar 

  58. Corsonello A, Onder G, Abbatecola AM, Guffanti EE, Gareri P, Lattanzio F. Explicit criteria for potentially inappropriate medications to reduce the risk of adverse drug reactions in elderly people: from Beers to STOPP/START criteria. Drug Saf. 2012;35(Suppl 1):21–8.

    Article  PubMed  Google Scholar 

  59. Gallagher P, O’Connor M, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89:845–54.

    Article  CAS  PubMed  Google Scholar 

  60. Dalleur O. Screening tools for the assessment of prescribing in older patients. Should we STOPP & START? PhD thesis, Université catholique de Louvain. Louvain; 2014.

    Google Scholar 

  61. Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;71:1013–9.

    Google Scholar 

  62. Wolfstadt J, Gurwitz J, Field T, Lee M, Kalkar S, Wu W, Rochon P. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008;23:451–8.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Strom B, Schinnar R, Aberra F, Bilker W, Hennessy S, Leonard C, Pifer E. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med. 2010;170:1578–83.

    Article  PubMed  Google Scholar 

  64. Scullin C, Scott M, Hogg A, McElnay J. An innovative approach to integrated medicine management. J Eval Clin Pract. 2007;13:781–8.

    Article  PubMed  Google Scholar 

  65. Ellis G, Whitehead M, Robinson D, O’Neill D, Langhorne P. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ. 2011;343:d6553.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012;29:453–62.

    Article  PubMed  Google Scholar 

  67. Onder G, van der Cammen T, Petrovic M, Somers A, Rajkumar C. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013;42:284–91.

    Article  PubMed  Google Scholar 

  68. Onder G, Lattanzio F, Battaglia M, Cerullo F, Sportiello R, Bernabei R, Landi F. The risk of adverse drug reactions in older patients: beyond drug metabolism. Curr Drug Metab. 2011;12:647–51.

    Article  CAS  PubMed  Google Scholar 

  69. Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging. 2010;27:507–21.

    Article  PubMed  Google Scholar 

  70. Schmader K, Hanlon J, Pieper C, Sloane R, Ruby C, Twersky J, Francis S, Branch L, Lindblad C, Artz M, Weinberger M, Feussner J, Cohen H. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116:394–401.

    Article  PubMed  Google Scholar 

  71. Onder G, Landi F, Fusco D, Corsonello A, Tosato M, Battaglia M, Mastropaolo S, Settanni S, Antocicco M, Lattanzio F. Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project. Drugs Aging. 2014;31:33–45.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mirko Petrovic .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Petrovic, M., Somers, A., Onder, G. (2016). Geriatric Pharmacotherapy: Optimisation Through Integrated Approach in the Hospital Setting. In: Stegemann, S. (eds) Developing Drug Products in an Aging Society. AAPS Advances in the Pharmaceutical Sciences Series, vol 26. Springer, Cham. https://doi.org/10.1007/978-3-319-43099-7_33

Download citation

Publish with us

Policies and ethics